Biological
Fluzone High Dose Vaccine
Fluzone High Dose Vaccine is a biological therapy with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Phase Distribution
Ph phase_2
2
67%
Ph phase_1
1
33%
Phase Distribution
1
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 2Efficacy & side effects
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 11 (33.3%)
Phase 22 (66.7%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completedphase_1
Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty
NCT02982915
completedphase_2
Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing IN Gammopathy Patients
NCT02566265
completedphase_2
Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV
NCT01205581
Clinical Trials (3)
Showing 3 of 3 trials
NCT02982915Phase 1
Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty
NCT02566265Phase 2
Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing IN Gammopathy Patients
NCT01205581Phase 2
Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV
All 3 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 3